A Smartphone App to Improve Medication Adherence in Patients With Type 2 Diabetes in Asia: Feasibility Randomized Controlled Trial
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Background: The efficacy of smartphone apps for improving medication adherence in type 2 diabetes is not well studied in Asian populations. Objective: This study aimed to determine the feasibility, acceptability, and clinical outcomes of using a smartphone app to improve medication adherence in a multiethnic Asian population with type 2 diabetes. Methods: We block randomized 51 nonadherent and digitally literate patients with type 2 diabetes between the ages of 21 and 75 years into two treatment arms (control: usual care; intervention: usual care+Medisafe app) and followed them up for 12 weeks. Recruitment occurred at a public tertiary diabetes specialist outpatient center in Singapore. The intervention group received email reminders to complete online surveys monthly, while the control group only received an email reminder(s) at the end of the study. Barriers to medication adherence and self-appraisal of diabetes were assessed using the Adherence Starts with Knowledge-12 (ASK-12) and Appraisal of Diabetes Scale (ADS) questionnaires at baseline and poststudy in both groups. Perception toward medication adherence and app usage, attitude, and satisfaction were assessed in the intervention group during and after the follow-up period. Sociodemographic data were collected at baseline. Clinical data (ie, hemoglobin A1c, body mass index, low-density lipoprotein, high-density lipoprotein, and total cholesterol levels) were extracted from patients’ electronic medical records. Results: A total of 51 (intervention group: 25 [49%]; control group: 26 [51%]) participants were randomized, of which 41 (intervention group: 22 [88.0%]; control group: 19 [73.1%]) completed the poststudy survey. The baseline-adjusted poststudy ASK-12 score was significantly lower in the intervention group than in the control group (mean difference: 4.7, P=.01). No changes were observed in the clinical outcomes. The average 12-week medication adherence rate of participants tracked by the app was between 38.3% and 100% in the intervention group. The majority (>80%) of the participants agreed that the app was easy to use and made them more adherent to their medication. Conclusions: Our feasibility study showed that among medication-nonadherent patients with type 2 diabetes, a smartphone app intervention was acceptable, improved awareness of medication adherence, and reduced self-reported barriers to medication adherence, but did not improve clinical outcomes in a developed Asian setting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The REDCap consortium: building an international community of software platform partners
Harris, P. A., Taylor, R., Minor, B. L., Elliott, V., Fernandez, M., O'Neal, L., McLeod, L., Delacqua, G., Delacqua, F., Kirby, J., et al. (2019) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2019.103208 · Cited by 24,013
Interventions for enhancing medication adherence
Nieuwlaat, R., Wilczynski, N., Navarro, T., Hobson, N., Jeffery, R., Keepanasseril, A., Agoritsas, T., Mistry, N., Iorio, A., Jack, S., et al. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000011.pub4 · Cited by 2,945 · cited 1×
“Adherence reinforcements will likely lead to short-term improvement in medication adherence [39].”
Whitehead, A. L., Julious, S. A., Cooper, C. L., & Campbell, M. J. (2016) · Statistical Methods in Medical Research · doi:10.1177/0962280215588241 · Cited by 1,936 · cited 1×
“A minimum of 12 participants per treatment arm is necessary to assess the objectives of the study in a two-arm trial [36], and 25 participants per arm is sufficient to account for a dropout rate of about 40% [37].”
Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost
Sokol, M. C., McGuigan, K. A., Verbrugge, R. R., & Epstein, R. S. (2005) · Medical Care · doi:10.1097/01.mlr.0000163641.86870.af · Cited by 1,729
Developing and evaluating complex interventions: the new Medical Research Council guidance
Craig, P., Dieppe, P., Macintyre, S., Michie, S., Nazareth, I., & Petticrew, M. (2013) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2012.09.010 · Cited by 1,658 · cited 2×
“Population-based interventions involving smartphone apps are often complex and multifaceted due to their challenges in controlling the environment [23].”
A systematic review of adherence with medications for diabetes
Cramer, J. A. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1218 · Cited by 1,203
Barriers to diabetes management: patient and provider factors
Nam, S., Chesla, C., Stotts, N. A., Kroon, L., & Janson, S. L. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.02.002 · Cited by 680 · cited 1×
“Asians constitute 60% of people with diabetes globally and are likely to have different cultural beliefs toward disease and medication management [20,21].”
Agarwal, S., LeFevre, A. E., Lee, J., L’Engle, K., Mehl, G., Sinha, C., & Labrique, A. (2016) · BMJ · doi:10.1136/bmj.i1174 · Cited by 639 · cited 1×
“We referred to the Consolidated Standards of Reporting Trials (CONSORT) eHealth checklist for feasibility trials [25] and the mobile health evidence reporting and assessment (mERA) checklist for mobile health [26] to report the findings of our study.”
Schmitt, A., Gahr, A., Hermanns, N., Kulzer, B., Huber, J., & Haak, T. (2013) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-11-138 · Cited by 587
Factors associated with poor glycemic control among patients with type 2 diabetes
Khattab, M., Khader, Y. S., Al-Khawaldeh, A., & Ajlouni, K. (2010) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2008.12.008 · Cited by 507 · cited 1×
“A different intervention period may change the study outcomes, although we acknowledge that the degree of medication nonadherence, personal motivation, and response to treatment can affect the HbA1c levels and add complexity to the interpretation of outcomes [41].”
Cited by
Hangaard, S., Laursen, S. H., Andersen, J. D., Kronborg, T., Vestergaard, P., Hejlesen, O., & Udsen, F. W. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211064633 · Cited by 55
Present and Future of Digital Health in Diabetes and Metabolic Disease
Rhee, S. Y., Kim, C., Shin, D. W., & Steinhubl, S. R. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0088 · Cited by 47
Enricho Nkhoma, D., Jenya Soko, C., Joseph Banda, K., Greenfield, D., Li, Y.-C. (., & Iqbal, U. (2021) · BMJ Health & Care Informatics · doi:10.1136/bmjhci-2020-100291 · Cited by 46
Shrivastava, T. P., Goswami, S., Gupta, R., & Goyal, R. K. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211060060 · Cited by 46
de Souza Ferreira, E., de Aguiar Franco, F., dos Santos Lara, M. M., Levcovitz, A. A., Dias, M. A., Moreira, T. R., de Oliveira, A. H. M., & Cotta, R. M. M. (2023) · BMC Health Services Research · doi:10.1186/s12913-023-09879-6 · Cited by 42
Metadata
- Authors
- Huang, Z., Tan, E., Lum, E., Sloot, P., Boehm, B. O., & Car, J.
- Venue
- JMIR mHealth and uHealth
- Publisher
- JMIR Publications Inc.
- Published
- 2019-09-12
- Volume
- 7
- Issue
- 9
- Pages
- e14914
- ISSN
- 2291-5222 (ISSN-L)
- OpenAlex
- W2972747751
- Cited by
- 97
- References
- 18
- FWCI
- 6.69
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Smartphone App to Improve Medication Adherence in Patients With Type 2 Diabetes in Asia: Feasibility Randomized Controlled Trial. https://app.cochat.ai/papers/10.2196/14914
- The paper
- Huang, Z., Tan, E., Lum, E., Sloot, P., Boehm, B. O., & Car, J. (2019). A Smartphone App to Improve Medication Adherence in Patients With Type 2 Diabetes in Asia: Feasibility Randomized Controlled Trial. JMIR mHealth and uHealth. https://doi.org/10.2196/14914
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.